In vitro expression of erythropoietin by transfected human mesenchymal stromal cells

Cytotherapy

Volumn 10, Issue 2, 2008, Pages 116-124

  Mok, P L ^a   Cheong, S K ^a,b   Leong, C F ^c   Othman, Ainoon ^c  

^a MAKNA HUKM Cancer Institute   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Erythropoietin; Lipofection; Mesenchymal stromal cells; Minimalistic immunologically defined gene expression (MIDGE); Nucleofection; Plasmid

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; ERYTHROPOIETIN;

ARTICLE; BONE MARROW BIOPSY; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; ELECTROPORATION; ERYTHROID CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; STROMA CELL; SUPERNATANT; CELL PROLIFERATION; CELL SEPARATION; CLONOGENIC ASSAY; CYTOLOGY; GENE VECTOR; GENETICS; MESODERM; METABOLISM; PLURIPOTENT STEM CELL;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; COLONY-FORMING UNITS ASSAY; ERYTHROID CELLS; ERYTHROPOIETIN; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; MESODERM; PLASMIDS; PLURIPOTENT STEM CELLS; STROMAL CELLS; TRANSFECTION;

EID: 43549104302     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701816996     Document Type: Article

References (32)

1. Dominici, M., Hofmann, TJ and Horwitz, EM. (2001) Bone marrow mesenchymal cells: Biological properties and clinical applications. J Biol Regul Homeost Agents, 5, pp. 28-37.
2. Mosca, JD, Hendricks, JK and Buyaner, D. (2000) Mesenchymal stromal cells as vehicles for gene delivery. Clin Ortho, 379, p. S71.
3. Campagnoli, C., Bellantuono, I. and Kumar, S. (2002) High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: potential targets for in utero ex vivo gene therapy. Br J Ophthalmol, 109, pp. 952-954.
4. Pereboeva, L., Komarova, S. and Mikheeva, G. (2003) Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells, 21, pp. 389-404.
5. Van Damme, A., Chuah, KL and Dell'accio, F. (2003) Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats. Haemophilia, 9, pp. 94-103.
6. Deng, Y., Guo, X. and Yuan, Q. (2003) Efficiency of adenoviral vector mediated CTLA4Ig gene delivery into mesenchymal stem cells. Chin Med J, 116, pp. 1649-1654.
7. PharmData Inc (2002) PharmData Signs Contracts with Leader in Stem Cell Research
8. Nakamura, K., Ito, Y. and Kawano, Y. (2004) Antitumour effect of genetically engineered mesenchymal stromal cells in a rat glioma model. Gene Therapy, 11, pp. 1155-1164.
9. Hamada, H., Kobune, M. and Nakamura, K. (2005) Mesenchymal stromal cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci, 96, pp. 149-156.
10. Donahue, RE, Kessler, SW and Bodine, D. (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med, 176, pp. 1125-1135.
11. Kanzawa, T., Ito, H. and Kondo, Y. (2003) Current and future gene therapy for malignant gliomas. J Biomed Biotechnol, 1, pp. 25-34.
12. Vorburger, SA and Hunt, KK. (2002) Adenoviral gene therapy. Oncologist, 7, pp. 46-59.
13. Schakowski, F., Gorschluter, M. and Junghans, C. (2001) A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfections of undesired DNA. Mol Ther, 3, pp. 793-800.
14. Krieg, AM. (2000) Minding the Cs and Gs. Mol Ther, 1, pp. 209-210.
15. Yew, NS, Zhao, H. and Wu, IH (2000) Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther, 1, pp. 255-262.
16. Mok, PL, Leong, CF and Cheong, SK. (2003) Isolation and identification of mesenchymal stem cells from human bone marrow. Malaysian J Pathol, 25, pp. 121-127.
17. Choong, PF, Mok, PL and Cheong, SK (2007) Generating neuron-like cells from BM-derived mesenchymal stromal cells in vitro. Cytotherapy, 9, pp. 170-183.
18. Fernandez, M., Simon, V. and Herrera, G. (1997) Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant, 20, pp. 265-271.
19. Erices, A., Conget, P. and Minguel, JJ. (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol, 109, pp. 235-242.
20. Leutenegger, CM, Boretti, FS and Mislin, CN (2000) Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline Interleukin-12 (IL-12), IL-16, or a CpG motif. J Virol, 74, pp. 10447-10457.
21. Lopez-Fuertes, L., Perez-Jimenez, E. and Vila-Coro, AJ (2002) DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. Vaccine, 21, pp. 247-257.
22. Moreno, S., Lopez-Fuertes, L. and Vila-Coro, AJ (2004) DNA immunization with minimalistic expression constructs. Vaccine, 22, pp. 1709-1716.
23. Ohno, M., Fornerod, M. and Mattaj, IW. (1998) Nucleocytoplasmic transport: The last 200 nanometers. Cell, 92, pp. 327-336.
24. Tanswell, AK, Staub, O. and Iles, R. (1998) Liposome-mediated transfection of fetal lung epithelial cells: DNA degradation and enhanced superoxide toxicity. Am J Physiol Lung Cell Mol Physiol, 275, pp. 452-460.
25. Liu, LN, Hendricks, K. and Buyaner, D. (2000) Systemic Erythropoietin Expression from Human Mesenchymal Stem Cells Depends on both Cell Adherence and Delivery Route, International Society for Hematotherapy and Graft Engineering, San Diego, CA
26. Bartholomew, A., Patil, S. and Mackay, A. (2001) Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther, 12, pp. 1527-1541.
27. Daga, A., Muraglia, A. and Quarto (2002) Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice. Gene Ther, 9, pp. 915-921.
28. Eliopoulus, N., Al-Khaldi, A. and Crosato, M. (2003) A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice. Nature, 10, pp. 478-489.
29. Zanta, MA, Belguise-Valladier, P. and Behr, JP. (1999) Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA, 96, pp. 91-96.
30. Zheng, C., Juhls, C. and Oswald, D. (2006) Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D. Vaccine, 24, pp. 4625-4629.
31. Li, M., Lin, Y-C and Su, KC The Seventh International Symposium on Micro Total Analysis System (μTAS2003), pp. 1265-1269.
32. Plank, C., Scherer, F. and Schillinger, U. (2002) Magnetofection: enhancing and targeting gene delivery by magnetic force. Eur Cells Mater, 3, pp. 79-80.